Thirty-five years after the FDA’s approval of the first mAb, these biologics account for nearly a fifth of the agency’s new drug approvals each year.
View Article
Explore how automation can scale cell therapy manufacturing efficiently.
View Article
Discover how a handful of Chinese hamsters gave rise to the CHO cells that transformed modern biology and pharmaceutical manufacturing.
View Magazine
ADCs are an emerging class of targeted therapeutics with the potential to improve the therapeutic index seen with traditional chemotherapy.
View Article
Explore how CHO cells power the production of life-changing medicines and the challenges behind turning these cells into mini protein factories.
View Publication